HA 130
- Product Name
- HA 130
- CAS No.
- 1229652-21-4
- Chemical Name
- HA 130
- Synonyms
- HA 150;HA 130;CS-1606;HA130 (HA-130);HA130;HA-130;HA 130;HA130 (Autotaxin Inhibitor);inhibit,HA 130,HA130,Phosphodiesterase (PDE),Inhibitor,HA-130;(3-((4-((3-(4-Fluorobenzyl)-2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)methyl)phenyl)boronic acid;(Z)-3-((4-((3-(4-fluorobenzyl)-2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)methyl)phenylboronic acid;B-[3-[[4-[[3-[(4-Fluorophenyl)Methyl]-2,4-dioxo-5-thiazolidinylidene]Methyl]phenoxy]Methyl]phenyl]boronic Acid
- CBNumber
- CB62546788
- Molecular Formula
- C24H19BFNO5S
- Formula Weight
- 463.29
- MOL File
- 1229652-21-4.mol
HA 130 Property
- storage temp.
- Store at -20°C
- solubility
- DMF:10.0(Max Conc. mg/mL);21.58(Max Conc. mM)
DMSO:30.11(Max Conc. mg/mL);64.99(Max Conc. mM)
Ethanol:0.5(Max Conc. mg/mL);1.08(Max Conc. mM) - form
- Powder
- color
- Light yellow to yellow
N-Bromosuccinimide Price
- Product number
- 10498
- Product name
- HA-130
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $72
- Updated
- 2024/03/01
- Product number
- 10498
- Product name
- HA-130
- Purity
- ≥98%
- Packaging
- 10mg
- Price
- $129
- Updated
- 2024/03/01
- Product number
- 10498
- Product name
- HA-130
- Purity
- ≥98%
- Packaging
- 25mg
- Price
- $178
- Updated
- 2024/03/01
- Product number
- 4196
- Product name
- HA130
- Purity
- ≥98%(HPLC)
- Packaging
- 10
- Price
- $225
- Updated
- 2021/12/16
- Product number
- 4196
- Product name
- HA130
- Purity
- ≥98%(HPLC)
- Packaging
- 50
- Price
- $927
- Updated
- 2021/12/16
HA 130 Chemical Properties,Usage,Production
Uses
HA 150 is a selective boronic acid-based inhibitor of autotaxin. Studies show that adminstration of HA 150 in mice results in rapid decrease of the lipid mediator lysophosphatidic acid (LPA) in the circulation. These findings suggest that HA 150 may provide useful therapeutic strategy in treating disorders associated with vascular development, inflammation, fibrotic disease, and tumor progression.
Uses
HA130 is a selective boronic acid-based inhibitor of autotaxin. Studies show that adminstration of HA130 in mice results in rapid decrease of the lipid mediator lysophosphatidic acid (LPA) in the circulation. These findings suggest that HA 150 may provide useful therapeutic strategy in treating disorders associated with vascular development, inflammation, fibrotic disease, and tumor progression.
storage
Store at -20°C
HA 130 Preparation Products And Raw materials
Raw materials
Preparation Products
HA 130 Suppliers
- Tel
- --
- Fax
- --
- info@trc-canada.com
- Country
- Canada
- ProdList
- 6038
- Advantage
- 71